PTGS2 and neoplasm: Upon suppressing of the IL-6/NF-κB/STAT3 signaling pathway, the level of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), and other genes involved in tumorigenesis would be downregulated, thereby inhibiting tumor progression.